{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:42Z","timestamp":1785862722352,"version":"3.56.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_207763"],"award-info":[{"award-number":["320030_207763"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM078114"],"award-info":[{"award-number":["GM078114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107927\/Z\/15\/Z"],"award-info":[{"award-number":["107927\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bpc.2024.107201","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:01:58Z","timestamp":1707980518000},"page":"107201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The processing intermediate of human amylin, pro-amylin(1\u201348), has in vivo and in vitro bioactivity"],"prefix":"10.1016","volume":"308","author":[{"given":"Giulia","family":"Mazzini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina N.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Garelja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zhyvoloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.T.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2024.107201_bb0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bpc.2024.107201_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/physrev.00028.2020","article-title":"The physiological control of eating: signals, neurons, and networks","volume":"102","author":"Watts","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bpc.2024.107201_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bpc.2024.107201_bb0020","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bpc.2024.107201_bb0025","series-title":"Proceedings, the Obesity Week","article-title":"Efficacy and safety of AM833 for weight loss: a dose-finding trial in adults with overweight\/obesity","author":"David","year":"2020"},{"key":"10.1016\/j.bpc.2024.107201_bb0030","series-title":"Proceedings, the Obesity Week","article-title":"Preclinical weight loss efficacy of AM833 in animal models of obesity","author":"Dahl","year":"2020"},{"key":"10.1016\/j.bpc.2024.107201_bb0035","series-title":"Proceedings, the Obesity Week","article-title":"AM833 \u2013 development of a long-acting amylin analogue","author":"Kruse","year":"2020"},{"key":"10.1016\/j.bpc.2024.107201_bb0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.121.000567","article-title":"AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison with six selective and nonselective agonists","volume":"377","author":"Fletcher","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bpc.2024.107201_bb0045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(21)00944-2","article-title":"Cagrilintide plus semaglutide for obesity management","volume":"397","author":"Becerril","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bpc.2024.107201_bb0050","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bpc.2024.107201_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bpc.2024.107201_bb0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","article-title":"Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment","volume":"85","author":"Ogawa","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bpc.2024.107201_bb0065","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis, American journal of physiology","volume":"298","author":"Lutz","year":"2010","journal-title":"Regulat., Integrat. Comparat. Physiol."},{"key":"10.1016\/j.bpc.2024.107201_bb0070","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bpc.2024.107201_bb0075","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0196-9781(98)00114-4","article-title":"Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.bpc.2024.107201_bb0080","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1096\/fj.202001456RRR","article-title":"Noradrenaline signaling in the LPBN mediates amylin\u2019s and salmon calcitonin\u2019s hypophagic effect in male rats","volume":"34","author":"Boccia","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bpc.2024.107201_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","article-title":"Brainstem mechanisms of amylin-induced anorexia","volume":"100","author":"Potes","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bpc.2024.107201_bb0090","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1038\/s41467-023-41986-0","article-title":"A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models","volume":"14","author":"Wirth","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bpc.2024.107201_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1751-0813.1994.tb03422.x","article-title":"Frequency of pancreatic amyloid deposition in cats from South-Eastern Queensland","volume":"71","author":"Lutz","year":"1994","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.bpc.2024.107201_bb0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0195-5616(95)50051-8","article-title":"Pathogenesis of feline diabetes mellitus","volume":"25","author":"Lutz","year":"1995","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.bpc.2024.107201_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00365529609031632","article-title":"Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats","volume":"31","author":"Arnelo","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bpc.2024.107201_bb0110","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107201_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bpc.2024.107201_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/BF00400803","article-title":"Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia","volume":"36","author":"Hoppener","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107201_bb0125","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2024.107201_bb0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/03009734.2017.1359219","article-title":"Islet amyloid in recent-onset type 1 diabetes-the DiViD study","volume":"122","author":"Westermark","year":"2017","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bpc.2024.107201_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/dci18-0054","article-title":"Probing the meaning of persistent Propeptide release in type 1 diabetes","volume":"42","author":"Kahn","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2024.107201_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","article-title":"Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets","volume":"52","author":"Udayasankar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107201_bb0150","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0909024107","article-title":"Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts","volume":"107","author":"Potter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2024.107201_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/19382014.2019.1599707","article-title":"Islet amyloidosis in a child with type 1 diabetes","volume":"11","author":"Beery","year":"2019","journal-title":"Islets"},{"key":"10.1016\/j.bpc.2024.107201_bb0160","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.17076","article-title":"Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients","volume":"22","author":"Chen","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bpc.2024.107201_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2010.12.028","article-title":"Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates","volume":"406","author":"Meng","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2024.107201_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/protein\/gzp036","article-title":"A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides","volume":"22","author":"Abedini","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bpc.2024.107201_bb0175","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","article-title":"Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death","volume":"55","author":"Marzban","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2024.107201_bb0180","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00125-006-0206-7","article-title":"Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets","volume":"49","author":"Paulsson","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2024.107201_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101585","article-title":"SORLA mediates endocytic uptake of proIAPP and protects against islet amyloid deposition","volume":"65","author":"Shih","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bpc.2024.107201_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/ol047480+","article-title":"Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide","volume":"7","author":"Abedini","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.bpc.2024.107201_bb0195","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1021\/ol101981b","article-title":"Efficient microwave-assisted synthesis of human islet amyloid polypeptide designed to facilitate the specific incorporation of labeled amino acids","volume":"12","author":"Marek","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.bpc.2024.107201_bb0200","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.peptides.2005.11.014","article-title":"Pharmacology of the human CGRP1 receptor in cos 7 cells","volume":"27","author":"Bailey","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.bpc.2024.107201_bb0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2024.107201_bb0210","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1074\/jbc.M307214200","article-title":"Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor","volume":"279","author":"Pham","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2024.107201_bb0215","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/mol.108.047142","article-title":"Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function","volume":"74","author":"Qi","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0220","article-title":"Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors","author":"Garelja","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0225","first-page":"R610","article-title":"Ontogeny of diet-induced obesity in selectively-bred Sprague-Dawley rats","volume":"285","author":"Ricci","year":"2003","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bpc.2024.107201_bb0230","article-title":"Influence of high energy diet and polygenic predisposition for obesity on postpartum health in rat dams","volume":"12","author":"Leuthardt","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bpc.2024.107201_bb0235","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jmb.2010.05.041","article-title":"Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide","volume":"400","author":"Marek","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2024.107201_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.bpc.2024.107201_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1054-3589(05)52002-7","article-title":"Tissue expression and secretion of amylin","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101444","article-title":"Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons","volume":"58","author":"Boccia","year":"2022","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.bpc.2024.107201_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170366","article-title":"Amylin brain circuitry","volume":"132","author":"Boccia","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.bpc.2024.107201_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","article-title":"Amylin - its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity","volume":"8","author":"Boyle","year":"2018","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.bpc.2024.107201_bb0265","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/j.2040-4603.2020.tb00140.x","article-title":"Systemic and central amylin, amylin receptor signaling, and their physiological and pathophysiological roles in metabolism","volume":"10","author":"Le Foll","year":"2020","journal-title":"Comprehen. Physiol."},{"key":"10.1016\/j.bpc.2024.107201_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bcpt.13427","article-title":"Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases","volume":"127","author":"Zakariassen","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bpc.2024.107201_bb0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000264394","article-title":"Roles of amylin in satiation, adiposity and brain development","volume":"63","author":"Lutz","year":"2010","journal-title":"Forum Nutrition"},{"key":"10.1016\/j.bpc.2024.107201_bb0280","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0196-9781(98)00127-2","article-title":"Behaviorally specific inhibition of sham feeding by amylin","volume":"19","author":"Asarian","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.bpc.2024.107201_bb0285","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/JME-17-0105","article-title":"The \u03b2-cell assassin: IAPP cytotoxicity","volume":"59","author":"Raleigh","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bpc.2024.107201_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158166","article-title":"Control of insulin secretion by production of reactive oxygen species: study performed in pancreatic islets from fed and 48-hour fasted Wistar rats","volume":"11","author":"Munhoz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2024.107201_bb0295","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1172\/JCI85210","article-title":"RAGE binds preamyloid IAPP intermediates and mediates pancreatic \u03b2 cell proteotoxicity","volume":"128","author":"Abedini","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bpc.2024.107201_bb0300","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pro.3425","article-title":"The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: establishing and exploiting common ground for novel amyloidosis therapies","volume":"27","author":"Abedini","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0305","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/dom.12873","article-title":"Dual role of interleukin-1\u03b2 in islet amyloid formation and its \u03b2-cell toxicity: implications for type 2 diabetes and islet transplantation","volume":"19","author":"Park","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bpc.2024.107201_bb0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ni.2591","article-title":"When metabolism met immunology","volume":"14","author":"Donath","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bpc.2024.107201_bb0315","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","article-title":"Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity","volume":"17","author":"Donath","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bpc.2024.107201_bb0320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41594-021-00646-x","article-title":"Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores","volume":"28","author":"Cao","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2024.107201_bb0325","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41594-020-0496-3","article-title":"Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly","volume":"27","author":"Gallardo","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2024.107201_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105705","article-title":"A new polymorphism of human amylin fibrils with similar protofilaments and a conserved core","volume":"25","author":"Li","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bpc.2024.107201_bb0335","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","article-title":"Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-beta fibrils","volume":"27","author":"Roder","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2024.107201_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","article-title":"Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes","volume":"166","author":"Bailey","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0345","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/acsptsci.8b00002","article-title":"Molecular signature for receptor engagement in the metabolic peptide hormone amylin","volume":"1","author":"Bower","year":"2018","journal-title":"ACS Pharmacol. & Translat. Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0355","doi-asserted-by":"crossref","first-page":"eabm9609","DOI":"10.1126\/science.abm9609","article-title":"A structural basis for amylin receptor phenotype","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bpc.2024.107201_bb0360","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2024.107201_bb0365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0370","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1210\/en.2007-1735","article-title":"Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors","volume":"149","author":"Morfis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpc.2024.107201_bb0375","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.bpc.2024.107201_bb0380","doi-asserted-by":"crossref","first-page":"eabf7258","DOI":"10.1126\/science.abf7258","article-title":"Structure and dynamics of the CGRP receptor in apo and peptide-bound forms","volume":"372","author":"Josephs","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bpc.2024.107201_bb0385","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","article-title":"Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor","volume":"561","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2024.107201_bb0390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acsptsci.9b00080","article-title":"Structure and dynamics of Adrenomedullin receptors AM(1) and AM(2) reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins","volume":"3","author":"Liang","year":"2020","journal-title":"ACS Pharmacol. & Translat. Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0395","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of Cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2024.107201_bb0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1","volume":"773","author":"Nilsson","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bpc.2024.107201_bb0405","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1021\/acs.jmedchem.6b00126","article-title":"Adrenomedullin 2.0: adjusting key levers for metabolic stability","volume":"59","author":"Schonauer","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bpc.2024.107201_bb0410","doi-asserted-by":"crossref","first-page":"e3530","DOI":"10.1002\/psc.3530","article-title":"Rational design of highly stabilized and selective adrenomedullin analogs","volume":"22","author":"Julke","year":"2023","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041343","article-title":"Fluorescent analogues of human alpha-calcitonin gene-related peptide with potent vasodilator activity","volume":"21","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpc.2024.107201_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2019.11.034","article-title":"Amylin and leptin interaction: role during pregnancy, lactation and neonatal development","volume":"447","author":"Boyle","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.bpc.2024.107201_bb0425","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/ijosup.2016.4","article-title":"Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure","volume":"6","author":"Lutz","year":"2016","journal-title":"Int. J. Obes. Suppl."},{"key":"10.1016\/j.bpc.2024.107201_bb0430","doi-asserted-by":"crossref","first-page":"R1215","DOI":"10.1152\/ajpregu.00446.2012","article-title":"Sex differences in the physiology of eating","volume":"305","author":"Asarian","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462224000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462224000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:02:42Z","timestamp":1759564962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462224000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":86,"alternative-id":["S0301462224000309"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2024.107201","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The processing intermediate of human amylin, pro-amylin(1\u201348), has in vivo and in vitro bioactivity","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2024.107201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107201"}}